U.S. National Economic Council Director Kevin Hassett on Thursday dismissed the possibility of China retaliating to tariffs ...

German pharmaceutical giant Boehringer Ingelheim said China remains a market of continued interest and would keep up the ...

Holdings reported that it expects to implement a 1-for-10 reverse stock split on its common stock effective Tuesday, April ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

Chinese biotech firm Duality Biotherapeutics launched an initial public offering (IPO) of up to HK$1.56 billion ($200.7 million) on Monday in Hong Kong, testing investor appetite amid a global stock ...

Shares of CASI Pharmaceuticals, Inc. (CASI) traded 5% higher on Thursday afternoon after the company announced that it has ...

Total deal value of innovator drug licensing agreements involving Chinese biopharma licensors has risen 66% to $41.5 billion ...

FedEx did not directly address the issue. Pharmaceutical products have long been spared from trade wars due to their ...

Several pharma CEOs met with Chinese President Xi Jinping in Beijing. President Donald Trump's reciprocal tariffs have mostly ...

HAIKOU, China, April 4, 2025 /PRNewswire/ -- China Pharma Holdings Inc. ("China Pharma" or the "Company") (NYSE American: CPHI) reported that it expects to implement a 1-for-10 reverse stock ...

HAIKOU, China, April 4, 2025 /PRNewswire/ -- China Pharma Holdings Inc. ("China Pharma" or the "Company") (NYSE American: CPHI) reported that it expects to implement a 1-for-10 reverse stock split ...